You’ve discovered a promising new orphan drug candidate, what next?
I just read about how Katharine Sepp and Joost Schulte effectively found the right partners to help them develop and raise funds for a drug that protects brain cells from accelerated aging that occurs in disorders such as Huntington and Parkinson’s diseases.
- Getting external validation first by getting an Orphan Drug Designation from the FDA
- Collaborated with a regulatory consultant
- Developed connections that worked on the same disease area; as far reaching and diverse as connections from Germany to Australia to the Netherlands
You can do all of the above all by yourself or you can leverage the World Orphan Drug Congress USA’s Pitch & Partner session where scientists with promising new drugs, medical device or pathways get a chance to present their discovery to pharma, funding agencies, VCs and other investors.
The World Orphan Drug Congress USA from April 21-22, 2016 with pre-conference workshops on April 20th will be held in Washington DC.
The Pitch & Partner Session is a dedicated 2-day stream on April 21-22. If you’re interested call Shahariar Zaman today at 646 619 1788 or email him at email@example.com
Slots are on a first come, first serve basis so call now to get your preferred slot. Check out the 2015 Pitch & Partner agenda here >
The production of World Orphan Drug Congress USA 2016 is well underway. Download the sponsorship prospectus to see how you can get involved.